Read More Analyst Ratings Downgrades News Price Target Jefferies Downgrades Medifast to Hold, Lowers Price Target to $150 By Benzinga Newsdesk Today, 3:56 PM Jefferies analyst Stephanie Wissink downgrades Medifast (NYSE:MED) from Buy to Hold and lowers the price target from $345 to $150. MED
Read More Contracts General Health Care IPOs News Offerings Healthcare Technology Firm Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare By Vandana Singh Today, 3:56 PM According to a registration statement with the SEC, Sophia Genetics SA (NASDAQ:SOPH) is looking to raise $100 million in an initial public… GE
Read More News Small Cap Top Stories Morning Brief: Top Financial Stories Dominating on Thursday, May 19 By Akanksha Bakshi Today, 3:56 PM CNBC CDC Looking Into 180 Cases Of Unexplained Pediatric Acute Hepatitis BA
Read More Analyst Ratings News Price Target EF Hutton Maintains Buy on Sachem Cap, Lowers Price Target to $5.5 By Benzinga Newsdesk Today, 3:56 PM EF Hutton analyst Edward Reilly maintains Sachem Cap (AMEX:SACH) with a Buy and lowers the price target from $7 to $5.5. SACH